Advanced Search

per page
  Report Title Date Provider Type Pgs Price

Alnylam Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

02 Oct 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Alnylam Pharmaceuticals Inc (ALNY-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

08 Oct 2015 Thomson Reuters Stock Report 11 $25.00

Trading Report for (ALNY). A detailed report, including free correlated market analysis, and updates.

Detailed Trading Report for ALNY. Entry levels, target prices, and risk controls are integral. In addition, free market anal...

08 Oct 2015 Stock Traders Daily 6 $20.00

ALNY: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

08 Oct 2015 New Constructs, LLC 10 $25.00

ValuEngine Rating and Forecast Report for ALNY

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

04 Oct 2015 ValuEngine, Inc. 11 $25.00

Alnylam Pharmaceuticals

03 Oct 2015 S&P Capital IQ – STARS Reports 11 $127.00


02 Oct 2015 Ford Investor Services, Inc. 1 $12.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ALNYLAM PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

02 Oct 2015 Jefferson Research 11 $20.00

Alnylam Pharmaceuticals, Inc. (ALNY) - Financial and Strategic SWOT Analysis Review

Alnylam Pharmaceuticals, Inc. (ALNY) - Financial and Strategic SWOT Analysis Review Summary Alnylam Pharmaceuticals, Inc., (A...

01 Oct 2015 GlobalData 62 $125.00

Wright Investors Service Comprehensive Report for Alnylam Pharmaceuticals, Inc.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

01 Oct 2015 Wright Reports 56 $75.00